These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8681939)

  • 21. A mutational analysis of receptor binding sites of interleukin-1 beta: differences in binding of human interleukin-1 beta muteins to human and mouse receptors.
    Grütter MG; van Oostrum J; Priestle JP; Edelmann E; Joss U; Feige U; Vosbeck K; Schmitz A
    Protein Eng; 1994 May; 7(5):663-71. PubMed ID: 8073036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A search within the IL-1 type I receptor reveals a peptide with hydropathic complementarity to the IL-1beta trigger loop which binds to IL-1 and inhibits in vitro responses.
    Heal JR; Bino S; Ray KP; Christie G; Miller AD; Raynes JG
    Mol Immunol; 1999 Dec; 36(17):1141-8. PubMed ID: 10698316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis.
    Ju G; Labriola-Tompkins E; Campen CA; Benjamin WR; Karas J; Plocinski J; Biondi D; Kaffka KL; Kilian PL; Eisenberg SP
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2658-62. PubMed ID: 1826365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple amino acid substitutions suggest a structural basis for the separation of biological activity and receptor binding in a mutant interleukin-1 beta protein.
    Auron PE; Quigley GJ; Rosenwasser LJ; Gehrke L
    Biochemistry; 1992 Jul; 31(29):6632-8. PubMed ID: 1386253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
    Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
    J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist.
    Symons JA; Young PR; Duff GW
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1714-8. PubMed ID: 7878046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-1 stimulates the expression of type I and type II interleukin-1 receptors in the rat insulinoma cell line Rinm5F; sequencing a rat type II interleukin-1 receptor cDNA.
    Bristulf J; Gatti S; Malinowsky D; Bjork L; Sundgren AK; Bartfai T
    Eur Cytokine Netw; 1994; 5(3):319-30. PubMed ID: 7524717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-6 as an endogenous pyrogen: induction of prostaglandin E2 in brain but not in peripheral blood mononuclear cells.
    Dinarello CA; Cannon JG; Mancilla J; Bishai I; Lees J; Coceani F
    Brain Res; 1991 Oct; 562(2):199-206. PubMed ID: 1773338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of glycosylated human interleukin-1alpha, neoglyco IL-1alpha, by coupling with D-galactose monosaccharide: biological activities in vitro.
    Nabeshima S; Chiba T; Takei Y; Watanabe S; Okuyama H; Onozaki K
    Glycoconj J; 1998 Jan; 15(1):69-74. PubMed ID: 9530958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1 beta: a possible site of prostaglandin synthesis responsible for fever.
    Cao C; Matsumura K; Yamagata K; Watanabe Y
    Brain Res; 1996 Sep; 733(2):263-72. PubMed ID: 8891309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines.
    Burger D; Rezzonico R; Li JM; Modoux C; Pierce RA; Welgus HG; Dayer JM
    Arthritis Rheum; 1998 Oct; 41(10):1748-59. PubMed ID: 9778216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential regulation of vascular smooth muscle nuclear factor kappa-B by G alpha q-coupled and cytokine receptors.
    Abbott KL; Robida AM; Davis ME; Pavlath GK; Camden JM; Turner JT; Murphy TJ
    J Mol Cell Cardiol; 2000 Mar; 32(3):391-403. PubMed ID: 10731439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-1 and its receptor.
    Dinarello CA; Savage N
    Crit Rev Immunol; 1989; 9(1):1-20. PubMed ID: 2523282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An interleukin 1 receptor antagonist blocks the IL-1-induced IL-6 paracrine production through a prostaglandin E2-related mechanism in multiple myeloma.
    Lu ZY; Bataille R; Poubelle P; Rapp MJ; Harousseau JL; Klein B
    Stem Cells; 1995 Aug; 13 Suppl 2():28-34. PubMed ID: 8520508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiol modulation inhibits the interleukin (IL)-1-mediated activation of an IL-1 receptor-associated protein kinase and NF-kappa B.
    Tewes F; Böl GF; Brigelius-Flohé R
    Eur J Immunol; 1997 Nov; 27(11):3015-21. PubMed ID: 9394832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin 1 receptor on fibroblasts from systemic sclerosis patients induces excessive functional responses to interleukin 1 beta.
    Kawaguchi Y; Harigai M; Suzuki K; Hara M; Kobayashi K; Ishizuka T; Matsuki Y; Tanaka N; Nakamura H
    Biochem Biophys Res Commun; 1993 Jan; 190(1):154-61. PubMed ID: 8422241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiidiotypic antibodies mimic molecular and functional properties of human IL-1 beta in vitro and in vivo.
    Soprana E; Vigo E; Verani A; Blom J; Siccardi AG; Vercelli D; Viale G
    Lymphokine Cytokine Res; 1994 Oct; 13(5):325-30. PubMed ID: 7858065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A synthetic peptide corresponding to 86-93 of the human type I IL-1 receptor binds human recombinant IL-1 (alpha and beta) and inhibits IL-1 actions in vitro and in vivo.
    Tanihara M; Suzuki Y; Fujiwara C; Abe C; Abe E; Suda T; Mizushima Y
    Biochem Biophys Res Commun; 1992 Oct; 188(2):912-20. PubMed ID: 1445332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor.
    Labriola-Tompkins E; Chandran C; Kaffka KL; Biondi D; Graves BJ; Hatada M; Madison VS; Karas J; Kilian PL; Ju G
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11182-6. PubMed ID: 1837145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Domains of rat interleukin 1 beta involved in type I receptor binding.
    Schotanus K; Holtkamp GM; Meloen RH; Puijk WC; Berkenbosch F; Tilders FJ
    Endocrinology; 1995 Jan; 136(1):332-9. PubMed ID: 7530194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.